The aims of this study were (i) to test the prediction ability of the biomarkers for clinical AD diagnosis in our cohort (over and above commonly used predictors such as APOE, age and AD PRS); and (ii) to identify genetic loci associated with these plasma biomarkers. The gene discussed is APOE; the disease is Alzheimer disease.